Moderna announced last week that it has begun dosing its first participants in Phase I clinical trials for an HIV vaccine that uses the same mRNA technology as the company’s COVID-19 vaccine.  The company, which is conducting the trial in ...

Since mid-December, the highly contagious Omicron variant of the novel coronavirus has dominated the latest surge in COVID-19 cases across the US. However, growing evidence is painting a picture of a variant that is less virulent than earlier versions of ...

A second person with HIV seems to have cleared the infection without stem cell treatments, raising optimism for efforts to develop a cure or vaccine. Researchers could find no evidence of intact virus in the patient, a 30-year-old woman from ...